Today’s Hot List: Heat Biologics (NASDAQ:HTBX), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Wal-Mart Stores Inc. (NYSE:WMT), JetBlue Airways Corporation (NASDAQ:JBLU), Zoe’s Kitchen (NYSE:ZOES)

On Monday shares of Heat Biologics, Inc. (NASDAQ:HTBX) closed at $5.75. On May 11, Heat Biologics, Inc. (NASDAQ:HTBX), announced that it has enrolled the first patient in a new Phase 1b trial of Viagenpumatucel-L (HS-110) in patients with non-small cell lung cancer (“NSCLC”). This new trial enables Heat to combine its HS-110 with multiple immune modulating strategies. HS-110 is Heat’s first product candidate in a series of proprietary ImPACT drugs designed to direct killer T cells to attack cancer. Daniel Morgensztern, M.D., Associate Professor of Medicine at the Washington University Siteman Cancer Center, is Lead Investigator of this new Phase 1b trial.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in last trading activity advanced 5.88% to close at $5.94. Company weekly performance is -14.53% while its quarterly performance stands at -22.56%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) is -64.85% away from its 52 week high. On May 15, it was reported that, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) and mAbxience have entered into a development and future distribution deal for Epirus’ lead program, BOW015 (infliximab, reference biologic Remicade), for Latin American markets, including Argentina, Chile, Ecuador, Paraguay, Uruguay and Venezuela.

On last trading day Wal-Mart Stores Inc. (NYSE:WMT) advanced 0.86% to close at $79.92. Its volatility for the week is 1.35% while volatility for the month is 1.24%. WMT’s sales growth for past 5 years was 3.50% and its EPS growth for past 5 years was 5.90%. Wal-Mart Stores Inc. (NYSE:WMT) monthly performance is 3.27%. Wal-Mart Stores Inc. (NYSE:WMT)’s new service, which will cost customers $50 a year, is expected to roll out this summer, according to The Associated Press. For one, the service won’t be the oh-so-sweet multimedia package deal that Amazon Prime is. Walmart Stores Inc., the retail giant is trying to ape Amazon’s success, by bringing the opportunity of getting products in a maximum of three days.

On Monday shares of JetBlue Airways Corporation (NASDAQ:JBLU) closed at $21.83. Company’s sales growth for last 5 years was 12.10% and EPS growth for next 5 years is recorded as 46.90%. JetBlue Airways Corporation (Nasdaq:JBLU) is expanding its service to Mexico starting with two of its key focus cities in Florida: Orlando and Fort Lauderdale. The Long Island City, NY-based airline on Oct. 1 will begin service to Mexico City’s Benito Juarez International Airport from Orlando International Airport, as well as service from Fort Lauderdale-Hollywood International Airport.

On last trading day Zoe’s Kitchen, Inc. (NYSE:ZOES) advanced 0.48% to close at $31.23. Its volatility for the week is 4.00% while volatility for the month is 3.96%. ZOES’s sales growth for past 5 years was 52.50% and its EPS growth for past 5 years was -21.40%. Zoe’s Kitchen, Inc. (NYSE:ZOES) monthly performance is -8.04%. Zacks downgraded shares of Zoe’s Kitchen Inc (NYSE:ZOES) from a buy rating to a hold rating in a research note released on Monday morning.

Top Wall Street Stories: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Express Scripts Holding (NASDAQ:ESRX), The Brink’s (NYSE:BCO), Fortress Investment Group (NYSE:FIG), General Motors (NYSE:GM)

On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $8.95. Company’s sales growth for last 5 years was 3.60%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced that it hosted a Key Opinion Leader (KOL) breakfast in New York City focused on offering insights into the evolution of the U.S. regulatory landscape, along with a clinician’s perspective on the approval and use of biosimilars. The event and live webcast took place on Monday, March 30, 2015.

Express Scripts Holding Company (NASDAQ:ESRX) in last trading activity increased 1.59% to close at $86.77. Company weekly performance is 3.22% while its quarterly performance stands at 0.94%. Express Scripts Holding Company (NASDAQ:ESRX) is -2.32% away from its 52 week high. Express Scripts Holding Company (NASDAQ:ESRX) executives have spoken out frequently about soaring costs from specialty drugs, and the St. Louis company threw its weight into this fight late last year by restricting coverage. It said in December it will no longer cover Sovaldi and Harvoni — two Gilead Sciences drugs that cost more than $80,000 each for a full course of treatment — or Johnson & Johnson’s Olysio except under limited circumstances.

On last trading day The Brink’s Company (NYSE:BCO) fell -1.25% to close at $27.63. Its volatility for the week is 2.25% while volatility for the month is 2.15%. BCO’s sales growth for past 5 years was 2.60% and its EPS growth for past 5 years was -17.80%. The Brink’s Company (NYSE:BCO) monthly performance is -1.32%. Standpoint Research cut shares of The Brink’s Company (NYSE:BCO) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning.

Fortress Investment Group LLC (NYSE:FIG) has 0.50% insider ownership while its institutional ownership stands at 58.40%. In last trading activity company’s stock closed at $8.07. The managing director of Fortress Investment Group LLC (NYSE:FIG) has been named chief financial officer of Communications Sales & Leasing Inc., the planned spinoff real estate investment trust of Windstream Holdings Inc., the company announced on Monday.

On Tuesday shares of General Motors Company (NYSE:GM) closed at $37.50. Company’s sales growth for last 5 years was 8.30% and EPS growth for next 5 years is recorded as 17.86%. General Motors Company (NYSE:GM) is debuting Wednesday its 2016 Chevrolet Malibu, which it says has better fuel economy, a roomier back seat and more-advanced technology.

Top Wall Street Stories: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Applied Materials (NASDAQ:AMAT), Cover-All Technologies Inc. (NYSEMKT:COVR), Extreme Networks (NASDAQ:EXTR), CIFC Corp. (NASDAQ:CIFC)

On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $9.25. Company’s sales growth for last 5 years was 3.60%. EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS) announced financial results for the fourth quarter and fiscal year ended December 31, 2014. Research and Development (R&D) expenses were $4.8 million for the fourth quarter of 2014 compared to $2.4 million for the fourth quarter of 2013, an increase of $2.4 million. This increase was primarily the result of development, manufacturing and commercialization expenses related to BOW015, as well as the advancement of other pipeline products.

Applied Materials, Inc. (NASDAQ:AMAT) in last trading activity decreased -0.31% to close at $23.90. Company weekly performance is -1.30% while its quarterly performance stands at -3.61%. Applied Materials, Inc. (NASDAQ:AMAT) is -6.81% away from its 52 week high. On March 17, Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc. (NASDAQ:AMAT) announced that it has participated in a Series B financing round for RayVio Corporation, an advanced UV light emitting diode (LED) solutions company developing proprietary semiconductor-based technology for manufacturing solid state ultraviolet (SSUV) LED products and applications.

On last trading day Cover-All Technologies Inc. (NYSEMKT:COVR) moved up 2.00% to close at $1.02. Its volatility for the week is 4.19% while volatility for the month is 4.98%. COVR’s sales growth for past 5 years was 7.20% and its EPS growth for past 5 years was -42.60%. Cover-All Technologies Inc. (NYSEMKT:COVR) monthly performance is -4.67%. On March 13, Cover-All Technologies Inc. (NYSEMKT:COVR) provided an update of its previously announced merger with Majesco. Manish D. Shah, Cover-All’s President and Chief Executive Officer, stated: “I am pleased to announce that Cover-All’s merger with Majesco continues to make progress. We have been informed by Majesco that on March 5, 2015, Mastek Ltd received shareholders’ and creditors’ approval to proceed with the demerger of the insurance business from Mastek and the reorganization under Majesco. The final approval of Majesco’s demerger from Mastek is expected to be completed by May 2015.”

Extreme Networks Inc. (NASDAQ:EXTR) has 1.60% insider ownership while its institutional ownership stands at 77.50%. In last trading activity company’s stock closed at $3.22. Extreme Networks Inc. (NASDAQ:EXTR) announced that its Purview™ breakthrough application analytics platform has been voted by readers as the best New Product of the Year 2015 at the Network Computing Awards held in London. Purview helps organizations make rapid and informed decisions to improve business efficiency, IT operations and the user experience.

On last trading day CIFC Corp. (NASDAQ:CIFC) decreased -0.49% to close at $8.14. Its volatility for the week is 4.56% while volatility for the month is 2.94%. CIFC’s sales growth for past 5 years was -44.30% and its EPS growth for past 5 years was 15.00%. CIFC Corp. (NASDAQ:CIFC) monthly performance is 1.50%. CIFC Corp. (NASDAQ:CIFC) declares a cash dividend of $0.10 per share. The dividend will be paid on April 15, 2015 to shareholders of record as of the close of business on April 2, 2015.

Stocks to Watch: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Delta Air Lines (NYSE:DAL), Bank of America (NYSE:BAC), Hovnanian Enterprises (NYSE:HOV), Varian Medical Systems (NYSE:VAR)

On Tuesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $9.51. EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), announced that it will host a conference call and webcast at 10 a.m. Eastern Time on Tuesday, March 24, 2015 to discuss fourth quarter and fiscal year 2014 financial results, and to discuss the Company’s progress. The call will be led by Amit Munshi, President and Chief Executive Officer, and Tom Shea, Chief Financial Officer.

Delta Air Lines, Inc. (NYSE:DAL) in last trading activity moved up 1.06% to close at $46.65. Company weekly performance is 7.44% while its quarterly performance stands at -1.95%. Delta Air Lines, Inc. (NYSE:DAL) is -8.46% away from its 52 week high. Virgin Australia and Delta Air Lines, Inc. (NYSE:DAL) say the immediate objective of their trans-Pacific joint-venture is to consolidate existing routes rather than add new services. Delta president Ed Bastien said his airline and Virgin have grown market share quickly since their partnership began in 2009 and the focus was on making sure that market share matured before adding incremental capacity.

On last trading day Bank of America Corporation (NYSE:BAC) decreased -0.25% to close at $16.09. Its volatility for the week is 1.69% while volatility for the month is 1.90%. BAC’s sales growth for past 5 years was -8.20% and its EPS growth for past 5 years was 26.50%. Bank of America Corporation (NYSE:BAC) monthly performance is -2.84%. Bank of America Corporation (NYSE:BAC) is opening a customer service center in Rio Rancho and bringing 300 jobs with it. The jobs will be for live video tellers to help at the banks new ATMs.

Hovnanian Enterprises Inc. (NYSE:HOV) has 4.10% insider ownership while its institutional ownership stands at 47.00%. In last trading activity company’s stock closed at $3.27. On March 12, Hovnanian Enterprises, (NYSE:HOV) posted a net loss of $14.4 million, compared with a net loss of $24.5 million in the first quarter of the previous year. Total revenues were $445.7 million in the fiscal 2015 first quarter, an increase of 22.4% compared with $364.0 million in the prior year’s first quarter.

On last trading day Varian Medical Systems, Inc. (NYSE:VAR) decreased -0.60% to close at $94.34. Its volatility for the week is 1.66% while volatility for the month is 1.31%. VAR’s sales growth for past 5 years was 6.60% and its EPS growth for past 5 years was 7.60%. Varian Medical Systems, Inc. (NYSE:VAR) monthly performance is 1.82%.On March 11, Varian Medical Systems (NYSE:VAR) announced that it has been selected to equip and service two new national proton therapy centers in England with the Varian ProBeam® proton therapy system. Under a public tender, Varian was selected as the preferred supplier to provide equipment and service to operate two three-room centers to be constructed in London and Manchester in a contract valued at up to £80 million.

Market Wrap Up: Bill Barrett Corp. (NYSE:BBG), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), OFS Capital (NASDAQ:OFS), JMP Group (NYSE:JMP), American Science & Engineering (NASDAQ:ASEI)

Bill Barrett Corp. (NYSE:BBG) reported Net income for 2014 was $15.1 million, or $0.31 per diluted common share, compared with a loss of $192.7 million, or ($4.06) per diluted common share in 2013. Net income for 2014 and 2013 includes impairment charges of $40.2 million (pre-tax) and $226.6 million (pre-tax), respectively, as well as a derivative gain of $199.3 million (pre-tax) in 2014 and a derivative loss of $28.4 million (pre-tax) in 2013. On Wednesday shares of Bill Barrett Corp. (NYSE:BBG) closed at $10.76. Company’s sales growth for last 5 years was -1.40% and EPS growth for next 5 years is recorded as 15.00%.

Equities researchers at Wedbush started coverage on shares of Epirus Biopharmaceuticals (NASDAQ:EPRS) in a research report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $13.00 price target on the stock. Wedbush’s price target would suggest a potential upside of 65.18% from the company’s current price. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in last trading activity advanced 15.11% to close at $10.36. Company weekly performance is 31.64% while its quarterly performance stands at 89.05%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) is -40.46% away from its 52 week high.

OFS Capital Corporation (NASDAQ:OFS), announced that, prior to the opening of the stock market on Friday, March 6, 2015, it will issue a press release announcing the Company’s fourth quarter and year end 2014 earnings results. On last trading day OFS Capital Corporation (NASDAQ:OFS) advanced 0.34% to close at $11.90. Its volatility for the week is 1.80% while volatility for the month is 2.33%. OFS Capital Corporation (NASDAQ:OFS) monthly performance is -1.57%.

JMP Group LLC (NYSE:JMP) February distribution is payable on or before March 13, 2015, to shareholders of record as of February 27, 2015. JMP Group LLC (NYSE:JMP) has 4.90% insider ownership while its institutional ownership stands at 34.10%. In last trading activity company’s stock closed at $7.36.

American Science and Engineering, Inc. (NASDAQ:ASEI) cash dividend payment of $0.5 per share is scheduled to be paid on March 03, 2015. On last trading day American Science & Engineering Inc. (NASDAQ:ASEI) fell -1.03% to close at $52.10. Its volatility for the week is 3.20% while volatility for the month is 4.00%. ASEI’s sales growth for past 5 years was -2.70% and its EPS growth for past 5 years was -9.70%. American Science & Engineering Inc. (NASDAQ:ASEI) monthly performance is 9.18%.

Stock in News: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), SodaStream International (NASDAQ:SODA), Cablevision Systems Corporation (NYSE:CVC), MannKind Corp. (NASDAQ:MNKD), Ballard Power Systems (NASDAQ:BLDP)

Wedbush assumed coverage on shares of Epirus Biopharmaceuticals (NASDAQ:EPRS) in a report released on Wednesday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $10.36. Company’s sales growth for last 5 years was 3.60%.

SodaStream International Ltd. (NASDAQ: SODA) reported Q4 EPS of $0.35, $0.17 better than the analyst estimate of $0.18. Revenue for the quarter came in at $126.5 million versus the consensus estimate of $127.23 million. SodaStream International Ltd. (NASDAQ:SODA) in last trading activity decreased -8.68% to close at $17.25. Company weekly performance is -9.21% while its quarterly performance stands at -25.32%. SodaStream International Ltd. (NASDAQ:SODA) is -63.53% away from its 52 week high.

Cablevision Systems Corporation (NYSE:CVC) reported better-than-expected earnings for the fourth quarter. The Bethpage, New York-based company posted quarterly earnings of $56 million, or $0.20 per share, compared to $51.8 million, or $0.19 per share, in the year-ago period. Its revenue gained 3% to $1.63 billion. However, analysts were expecting earnings of $0.19 per share on revenue of $1.63 billion. On last trading day Cablevision Systems Corporation (NYSE:CVC) decreased -6.26% to close at $18.56. Its volatility for the week is 3.37% while volatility for the month is 2.79%. CVC’s sales growth for past 5 years was 2.60% and its EPS growth for past 5 years was 20.70%. Cablevision Systems Corporation (NYSE:CVC) monthly performance is -5.88%.

MannKind Corp.’s (NASDAQ:MNKD) reported fourth-quarter 2014 loss of 9 cents per share was narrower than the year-ago loss of 16 cents per share and the Zacks Consensus Estimate of a loss of 10 cents. MannKind Corp. (NASDAQ:MNKD) has 0.70% insider ownership while its institutional ownership stands at 25.60%. In last trading activity company’s stock closed at $6.91.

Ballard Power Systems Inc. (NASDAQ:BLDP) reported Q4 net income was ($17.5) million or ($0.13) per share; full year net income was ($28.2) million or ($0.22) per share, declines of 41% and 11%, respectively. Q4 cash used by operating activities was ($8.2) million; for the full year cash used by operating activities increased 19%, to ($20.7) million. On last trading day Ballard Power Systems Inc. (NASDAQ:BLDP) moved up 1.11% to close at $2.74. Its volatility for the week is 7.43% while volatility for the month is 7.90%. BLDP’s sales growth for past 5 years was 0.60% and its EPS growth for past 5 years was -19.30%. Ballard Power Systems Inc. (NASDAQ:BLDP) monthly performance is 76.77%.

Active Movers: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), ZIOPHARM Oncology (NASDAQ:ZIOP), British American Tobacco plc (NYSEMKT:BTI), CaesarStone Sdot-Yam (NASDAQ:CSTE), Natural Grocers (NYSE:NGVC)

On 30 January, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced the pricing of an underwritten public offering of 9.6 million shares of its common stock, offered at a price to the public of $5.00 per share. On Thursday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $7.00. Company’s sales growth for last 5 years was 3.60%.

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced that the underwriters for its recently announced underwritten public offering of common stock have exercised in full their option to purchase an additional 1,500,000 shares of common stock at a public offering price of $8.75 per share. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) in last trading activity advanced 8.12% to close at $9.99. Company weekly performance is 15.09% while its quarterly performance stands at 192.11%.

Nomura reaffirmed their buy rating on shares of British American Tobacco plc (NYSEMKT:BTI) in a report released on Thursday. Nomura currently has a ($58.98) price objective on the stock. On last trading day British American Tobacco plc (NYSEMKT:BTI) advanced 1.01% to close at $112.59. Its volatility for the week is 0.93% while volatility for the month is 1.17%. BTI’s sales growth for past 5 years was 4.70% and its EPS growth for past 5 years was 10.80%. British American Tobacco plc (NYSEMKT:BTI) monthly performance is 4.27%.

Caesarstone Sdot-Yam Ltd. (NASDAQ:CSTE), reported financial results for its fourth quarter and fiscal year ended December 31, 2014. Revenues in the fourth quarter of 2014 increased by 17.4% to $113.6 million compared to $96.8 million in the prior year. On a constant currency basis, fourth quarter revenue growth was 22.7% year-over-year. CaesarStone Sdot-Yam Ltd. (NASDAQ:CSTE) has 49.95% insider ownership while its institutional ownership stands at 57.70%. In last trading activity company’s stock closed at $62.47.

Instacart partnered with Natural Grocers by Vitamin Cottage, Inc. (NYSE:NGVC) to provide grocery delivery service to customers in Portland in as little as one hour. On last trading day Natural Grocers by Vitamin Cottage, Inc. (NYSE:NGVC) decreased -1.97% to close at $29.83. Its volatility for the week is 3.72% while volatility for the month is 4.66%. NGVC’s sales growth for past 5 years was 20.40% and its EPS growth for past 5 years was -36.10%. Natural Grocers by Vitamin Cottage, Inc. (NYSE:NGVC) monthly performance is 15.26%.

Top News: EPIRUS Biopharmaceuticals (NASDAQ:EPRS), LoJack Corporation (NASDAQ:LOJN), General Electric Company (NYSE:GE), Diebold, Incorporated (NYSE:DBD), Applied Industrial Technologies (NYSE:AIT)

On January 30, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) announced the pricing of an underwritten public offering of 9.6 million shares of its common stock, offered at a price to the public of $5.00 per share. On Wednesday shares of EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) closed at $5.89. Company’s sales growth for last 5 years was 3.60%.

On February 28, LoJack Corporation (NASDAQ:LOJN) announced that LoJack Equipment Ireland Ltd. (“LoJack Ireland”), which manages the company’s international licensee relationships, has reached a legal settlement with Tracker do Brasil LTDA (“Tracker”). The agreement results in $5 million of total value to LoJack. Specifically, Tracker will pay LoJack $2 million in cash and will provide $3 million of value in the form of gross margin through product sales. LoJack Corporation (NASDAQ:LOJN) in last trading activity moved up 5.65% to close at $2.43. Company weekly performance is 11.98% while its quarterly performance stands at -9.67%. LoJack Corporation (NASDAQ:LOJN) is -64.53% away from its 52 week high.

General Electric Company (NYSE:GE) disclosed in a regulatory filing that its board amended and restated the Company’s By-Laws to implement a proxy access by-law, effective February 6, 2015. On Wednesday shares of General Electric Company (NYSE:GE) closed at $24.77. Company’s sales growth for last 5 years was -0.80% and EPS growth for next 5 years is recorded as 7.41%.

Diebold, Incorporated (NYSE:DBD) and Eagle Eye Networks, Inc., have formalized the security industry’s first national strategic alliance to deliver cloud-based video services. The new video solutions will offer services that stream and store live and recorded video, provide flexible cloud storage, and generate notification and real-time analytics. Diebold, Incorporated (NYSE:DBD) has 0.36% insider ownership while its institutional ownership stands at 99.70%. In last trading activity company’s stock closed at $33.56.

Applied Industrial Technologies, Inc. (NYSE:AIT) cash dividend payment of $0.27 per share is scheduled to be paid on February 27, 2015. Shareholders who purchased AIT stock prior to the ex-dividend date are eligible for the cash dividend payment. On last trading day Applied Industrial Technologies, Inc. (NYSE:AIT) decreased -1.24% to close at $42.11. Its volatility for the week is 1.73% while volatility for the month is 2.80%. AIT’s sales growth for past 5 years was 5.00% and its EPS growth for past 5 years was 21.90%. Applied Industrial Technologies, Inc. (NYSE:AIT) monthly performance is 1.59%.

Why These Are Hot: GlobalSCAPE (NYSEMKT:GSB), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Iteris (NYSEMKT:ITI), Amedica (NASDAQ:AMDA), Biocept (NASDAQ:BIOC)

On 5 February, GlobalSCAPE, Inc. (NYSEMKT: GSB) announced the initiation of a quarterly cash dividend program commencing the second quarter of 2015. The initial cash dividend will be $0.015 per share with the applicable second quarter record and payment dates to be determined. On Tuesday shares of GlobalSCAPE, Inc. (NYSEMKT: GSB) closed at $3.06. Company’s sales growth for last 5 years was 9.00%.

EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) announced that the Company is scheduled to present a corporate overview at the Leerink Global Healthcare Conference in New York City on Thursday, February 12, 2015 at 11:35 a.m. Eastern Time. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) in last trading activity advanced 5.72% to close at $5.91. Company weekly performance is 18.20% while its quarterly performance stands at 31.04%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) is -66.03% away from its 52 week high.

On 4 February, Iteris, Inc. (NYSEMKT: ITI) announced that BASF has entered into an agreement to leverage Iteris’ ClearAg high-resolution field level weather information. On last trading day Iteris, Inc. (NYSEMKT: ITI) moved down -2.67% to close at $1.82. Its volatility for the week is 4.10% while volatility for the month is 2.96%. ITI’s sales growth for past 5 years was -0.30% and its EPS growth for past 5 years was -33.20%. Iteris, Inc. (NYSEMKT:ITI) monthly performance is 6.43%.

On 4 February, Amedica Corporation (NASDAQ:AMDA) announced that the U.S. Food and Drug Administration (FDA) has expanded the indications of Amedica’s silicon nitride interbody fusion products to include multi-level cervical treatment. Amedica Corporation (NASDAQ:AMDA) has 1.50% insider ownership while its institutional ownership stands at 13.60%. In last trading activity company’s stock closed at $0.65.

Biocept, Inc. (NASDAQ:BIOC) announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock and warrants to purchase up to an aggregate of 8,000,000 shares of its common stock at a combined offering price of $1.25. On last trading day Biocept, Inc. (NASDAQ:BIOC) moved down -33.51% to close at $1.23. Its volatility for the week is 22.24% while volatility for the month is 15.49%. Biocept, Inc. (NASDAQ:BIOC) monthly performance is -62.15%.

Biotech Volatile Stocks: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Kite Pharma (NASDAQ:KITE), EPIRUS Biopharmaceuticals (NASDAQ:EPRS), Ohr Pharmaceutical (NASDAQ:OHRP), Cellular Biomedicine (NASDAQ:CBMG)

On 5 February, RXi Pharmaceuticals Corporation (NASDAQ: RXII), announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone™ with Hapten Pharmaceuticals, LLC. On Tuesday shares of RXi Pharmaceuticals Corporation (NASDAQ:RXII) closed at $1.26.

On 3 February, Kite Pharma, Inc., (NASDAQ:KITE) announced the appointments of Salah D. Kivlighn, Ph.D., as Vice President, Marketing, and Anthony J. Polverino, Ph.D., as Vice President, Research. Kite Pharma, Inc. (NASDAQ:KITE) in last trading activity increased 5.41% to close at $63.88. Company weekly performance is 0.30% while its quarterly performance stands at 38.90%. Kite Pharma, Inc. (NASDAQ:KITE) is -28.39% away from its 52 week high.

On 30 January, EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced the pricing of an underwritten public offering of 9.6 million shares of its common stock, offered at a price to the public of $5.00 per share. On last trading day EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) increased 5.72% to close at $5.91. Its volatility for the week is 10.96% while volatility for the month is 10.89%. EPRS’s sales growth for past 5 years was 3.60% and its EPS growth for past 5 years was 30.60%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) monthly performance is -27.31%.

For the first quarter ended December 31, 2014, Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) reported a net loss of approximately $4.6 million, or $0.18 per share, compared with $2.0 million, or $0.10 per share, in the first quarter of 2013. Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) has 2.10% insider ownership while its institutional ownership stands at 23.70%. In last trading activity company’s stock closed at $7.87.

Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced its acquisition of Chinese PLA General Hospital’s (“PLAGH”, Beijing, also known as “301 Hospital”) Chimeric Antigen Receptor T cell (CAR-T) therapy, its recombinant expression vector CD19, CD20, CD30 and Human Epidermal Growth Factor Receptor’s (EGFR or HER1) Immuno-Oncology patents. On last trading day Cellular Biomedicine Group Inc. (NASDAQ:CBMG) increased 0.85% to close at $23.60. Its volatility for the week is 12.86% while volatility for the month is 8.90%. CBMG’s EPS growth for past 5 years was -19.20%. Cellular Biomedicine Group Inc. (NASDAQ:CBMG) monthly performance is 46.40%.